Full-Time
Behavior change platform for weight loss
$166k - $224k/yr
Senior
New York, NY, USA
In-office presence required 2 days per week in New York, NY.
Upload your resume to see how it matches 6 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Noom focuses on helping individuals change their behaviors related to weight loss and health. The platform combines artificial intelligence, mobile technology, and psychological principles to provide personalized coaching and support. Users engage with behavior change courses and a virtual diabetes prevention program that has received recognition from the CDC. Unlike many competitors, Noom emphasizes a holistic approach that integrates mental and emotional aspects of health, making it more than just a diet plan. The goal of Noom is to improve health outcomes for users and enhance treatment results for patients in collaboration with healthcare and pharmaceutical companies.
Company Size
1,001-5,000
Company Stage
Series F
Total Funding
$668.3M
Headquarters
New York City, New York
Founded
2008
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
401(k) Retirement Plan
Paid Holidays
Paid Vacation
Disability Insurance
Wellness Program
Professional Development Budget
Hybrid Work Options
Remote Work Options
What You Should Know:– Noom, a digital healthcare company focused on chronic disease prevention and empowering healthy living announced an agreement with Gifthealth, the LillyDirect® pharmacy provider of Eli Lilly and Company.– The collaboration aims to simplify access to FDA-approved Zepbound® (tirzepatide) single-dose vials for Noom’s members who have an on-label prescription from their physician.Evolving Noom’s Weight Management Approach:This integration represents an evolution of Noom’s comprehensive approach to weight management. By enabling a streamlined solution for members prescribed FDA-approved medications, Noom is enhancing its support for those seeking effective weight management strategies. Noom has offered branded medications since 2023, and this latest integration further emphasizes the company’s commitment to a simpler and more accessible patient experience.Streamlined Access and TrackingThe collaboration with LillyDirect/Gifthealth will allow Noom members with on-label prescriptions for Zepbound® vials to receive fill-status and shipping updates directly through the Noom interface. This feature aims to improve transparency and convenience for patients managing their medication.Noom’s Comprehensive GLP-1 CompanionIn addition to facilitating access to Zepbound®, Noom offers a comprehensive GLP-1 companion program to support members in making health a habit alongside the medication. This program is designed to improve treatment outcomes and persistence and includes:GLP-1 Med Tracker: This feature provides reminders, a medication log, and integrated side-effect support to promote persistence and enhance weight loss outcomes.This feature provides reminders, a medication log, and integrated side-effect support to promote persistence and enhance weight loss outcomes. Protein-focused nutrition support: Members receive guidance and tools, including photo meal logging, to support protein intake and preserve lean mass.Members receive guidance and tools, including photo meal logging, to support protein intake and preserve lean mass
This partnership combines Noom's advanced digital health management platform with Collective Health's robust benefits administration infrastructure and personalized care navigation to deliver a seamless solution and superior member experience for weight management, including access to GLP-1 class drugs and other anti-obesity medications.
What You Should Know:– Collective Health, a leader in employee health benefits, and Noom Health, the enterprise division of digital healthcare leader Noom announced a partnership to deliver Collective Health + Noom Med with SmartRx.– The new program provides employers with an integrated weight management solution that includes a GLP-1 drug program, addressing the growing need for effective and affordable weight loss strategies.Addressing the Obesity EpidemicWith obesity affecting over 40% of U.S. adults and projected to have a global economic impact exceeding $4.32 trillion annually by 2035, the partnership aims to provide effective and affordable weight loss options. The Collective Health + Noom Med with SmartRx program offers a holistic approach to weight loss, combining access to GLP-1 class drugs and other anti-obesity medications with lifestyle support.Cost Savings and Improved AccessThe program is designed to deliver cost savings, proactive member engagement, efficient medication access, and comprehensive lifestyle support. By offering direct, cost-effective access to GLP-1 medications, the program bypasses traditional intermediaries and reduces overall treatment costs for Collective Health clients and their members. On average, clients covering GLP-1 drugs for weight loss could see potential savings of 28% by transitioning to the Collective Health + Noom Med with SmartRx program*.Key Features of Collective Health + Noom Med with SmartRxAdaptive Cost-Sharing: The program offers customizable member cost-sharing levels for GLP-1 medications, providing predictable and manageable expenses for both employers and employees.The program offers customizable member cost-sharing levels for GLP-1 medications, providing predictable and manageable expenses for both employers and employees. Clinically Appropriate Prescriptions: Noom’s clinicians ensure proper GLP-1 prescriptions for eligible individuals, providing end-to-end care.Noom’s clinicians ensure proper GLP-1 prescriptions for eligible individuals, providing end-to-end care
The Navy awarded Noom the contract for $466,600 in September 2024.
Noom, best-known for its weight loss app and more recent GLP-1 offering, launched an HRT program for menopause in late February, and telehealth company Hims & Hers plans to roll out at-home testing over the next year to enable care for low testosterone, perimenopause, and menopause.